Keratanase II from Bacillus circulans, Recombinant1vial

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4S,4'S,5R,5'R)-, 98%, 1g

6-Nitro-1,2-benzisoxazol, 95.0%, 100mg

4-(Cyanomethyl)phenylboronic Acid (contains varying amounts of Anhydride)5g

(3-Chloro-2-hydroxyphenyl)boronic acid, 95.0%, 1g

4''-(Pentyloxy)-[1,1':4',1''-terphenyl]-4-carboxylic acid, 95.0%, 1g

1-(4-(tert-Butyl)phenyl)piperidine-4-carboxylic acid, 97%, 500mg

1-(BENZO[D][1,3]DIOXOL-6-YL)-2-NITROETHANOL, 95.0%, 250mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-piperidone>98.0%(HPLC)5g

2-ETHENYL-4,4,6-TRIMETHYL-1,3,2-DIOXABORINANE, 95%, 100mg

5-Amino-3-methylbenzo[d]isoxazole, 95.0%, 1g

4-Oxo-1-(p-tolyl)cyclohexane-1-carbonitrile, 95%, 1g

6-Aminoquinoxaline>98.0%(GC)(T)1g